ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OLMA Olema Pharmaceuticals Inc

12.36
-0.10 (-0.80%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 653,952
Bid Price 11.54
Ask Price 17.95
News (1)
Day High 12.78

Low
7.37

52 Week Range

High
17.7911

Day Low 12.14
Share Name Share Symbol Market Stock Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.10 -0.80% 12.36 23:00:09
Open Price Low Price High Price Close Price Previous Close
12.37 12.14 12.78 12.36 12.46
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
9,337 653,952 US$ 12.39 US$ 8,102,273 - 7.37 - 17.7911
Last Trade Type Quantity Price Currency
15:35:25 6 US$ 12.41 USD

Olema Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
690.55M 55.91M - 0 -96.66M -1.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Olema Pharmaceuticals News

Date Time Source News Article
6/14/202415:39Edgar (US Regulatory)Form 8-K - Current report
6/06/202417:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
6/06/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202409:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
6/06/202409:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
6/04/202420:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202415:28GlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq..
6/04/202414:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
6/03/202413:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/31/202411:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/28/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/28/202406:03GlobeNewswire Inc.Olema Oncology to Participate in Upcoming Investor..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OLMA Message Board. Create One! See More Posts on OLMA Message Board See More Message Board Posts

Historical OLMA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.7914.2011.82513.071,084,313-0.43-3.36%
1 Month9.7915.35578.5112.091,364,6192.5726.25%
3 Months11.3815.35578.5111.24937,9280.988.61%
6 Months12.7816.7758.5112.11899,202-0.42-3.29%
1 Year9.2517.79117.3712.02708,1553.1133.62%
3 Years29.2832.772.0011.23476,455-16.92-57.79%
5 Years47.0060.272.0012.87428,003-34.64-73.70%

Olema Pharmaceuticals Description

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.

Your Recent History

Delayed Upgrade Clock